LYZ and chronic kidney disease: With the exception of the study by Glorieux et al. 37, and an in vitro study suggesting anti-inflammatory properties of LYZ on human proximal tubular epithelial cells (HK-2 cells)82, studies of LYZ in the context of CKD are lacking.